Last reviewed · How we verify
NCT05561465
Pterygomaxillary Disjunction With Interpositional Y-shape Plate in Patients With Temporomandibular Joint Derangement
NA trial testing Pterygomaxillary disjunction with interposition Y-shape plate in Temporomandibular Disorder in 12 participants. Completed in 30 June 2022.
30 June 2022
Quick facts
| Lead sponsor | Hams Hamed Abdelrahman |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 1 November 2021 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Pterygomaxillary disjunction with interposition Y-shape plate
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
Sponsor
Hams Hamed Abdelrahman — full company profile →
Who can join
Adults 18 to 40, any sex, with Temporomandibular Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Temporomandibular joint internal derangement (TMJ ID) is the most frequent type of temporomandibular disorder (TMDs)which is managed by different therapeutic modalities. it begins with conservative methods like medical treatment, physiotherapy, thermotherapy, and bites appliance therapy. Surgical intervention is a controversial issue in cases not responding to conservative methods. A novel minimally invasive surgical technique which is extracapsular trans oral (Pterygomaxillary disjunction) has been advocated as a minimally invasive extracapsular technique that preserves TMJ integrity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05561465
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Other Hams Hamed Abdelrahman trials
Trials by the same sponsor.
- NCT07044882 — Hydrodynamic Piezoelectric Technique in Internal Sinus Lift · NA · not yet recruiting
- NCT07082634 — Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone · NA · not yet recruiting
- NCT07044895 — Diode Laser Photocoagulation With Immediate Implant Placement · NA · not yet recruiting
- NCT06759311 — Two Different Minimal Invasive Techniques in Caries Removal of Primary Teeth · NA · active not recruiting
- NCT07103564 — The Effect of Local Melatonin Application Around Immediately Placed Implants in the Maxillary Premolar · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05561465 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hams Hamed Abdelrahman
- Last refreshed: 30 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05561465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing